本文已被:浏览 170次 下载 108次
投稿时间:2024-12-31 网络发布日期:2025-11-26
投稿时间:2024-12-31 网络发布日期:2025-11-26
中文摘要: 目的 探讨老年肌肉减少症(肌少症)患者血清血管内皮生长因子(VEGF)、骨形态发生蛋白-2(BMP-2)水平及其诊断价值。方法 回顾性纳入2022年2月至2024年2月于湖北省第三人民医院体检的290例老年人作为研究对象,其中确诊为肌少症的158例作为病例组,非肌少症的132例作为对照组。根据相关共识将病例组患者分为不同病情期别:肌少症前期组(42例)、肌少症组(64例)、重度肌少症组(52例)。酶联免疫吸附测定检测血清VEGF、BMP-2水平,Pearson法分析二者与患者临床指标的相关性;Logistic回归分析老年肌少症的影响因素,受试者工作特征(ROC)曲线分析VEGF、BMP-2及其联合对老年肌少症的诊断价值。结果 病例组血清VEGF水平低于对照组[(189.49±31.59)pg/mL vs(220.17±26.78)pg/mL,t=8.820,P<0.05],BMP-2水平高于对照组[(3.31±0.68)pg/mL vs(2.68±0.55)pg/mL,t=8.559,P<0.05]。病例组中,按肌少症前期、肌少症、重度肌少症之序,患者血清VEGF水平依次降低,BMP-2水平依次升高(P<0.05)。病例组四肢骨骼肌质量(ASM)、全身骨骼肌质量(SM)、相对骨骼肌指数(RASM)、握力、步速低于对照组(P<0.05)。VEGF水平分别与ASM、SM、RASM、握力、步速呈正相关关系(P<0.05);而BMP-2水平分别与该5项指标水平呈负相关关系(P<0.05)。多因素logistic分析结果显示,高BMP-2是老年人发生肌少症的独立危险因素,高RASM、VEGF则是保护因素(P<0.05)。VEGF、BMP-2联合诊断老年肌少症患者的曲线下面积(AUC)为 0.882,优于 VEGF、BMP-2 分别单一诊断的 AUC(0.808,0.793)(Z=3.436,Z=3.930,P<0.05)。结论 老年肌少症患者血清VEGF 水平下降、BMP-2水平上升,二者与病程进展密切相关,联合诊断效能较优,有望成为老年肌少症患者的临床预测标记物。
Abstract:Objective To investigate the levels of serum vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2(BMP-2)in elderly patients with sarcopenia and their diagnostic values. Methods A total of 290 elderly individuals who underwent physical examinations at Third People's Hospital of Hubei Province from February 2022 to February 2024 were included as the study subjects. Among them,158 elderly individuals diagnosed with sarcopenia were included in the case group,while 132 elderly individuals without sarcopenia were included in the control group. According to the relevant consensus,the patients in the case group were divided into different stages:pre-sarcopenia group(42 cases),sarcopenia group(64 cases)and severe sarcopenia group(52 cases). Enzyme linked immunosorbent assay was applied to detect serum VEGF and BMP-2 levels,and the correlations of them with clinical indicators were analyzed by Pearson method. Logistic regression analysis was performed to analyze the influencing factors of senile sarcopenia,and the diagnostic value of VEGF,BMP-2 and their combination in senile sarcopenia were analyzed by receiver operating characteristic(ROC)curve. Results Compared with the control group,the serum VEGF level in the case group was lower[(189.49±31.59)pg/mL vs(220.17±26.78)pg/mL,t=8.820,P<0.01],and the BMP-2 level was higher[(3.31±0.68)pg/mL vs(2.68±0.55)pg/mL,t=8.559,P<0.01]. In the case group,according to the order of pre-sarcopenia,sarcopenia and severe sarcopenia,the serum VEGF level decreased and BMP-2 level increased in turn(P<0.05). The appendicular skeletal muscle mass(ASM),skeletal muscle mass(SM),relative appendicular skeletal muscle index(RASM),grip strength,and gait speed of the case group were lower than those of the control group(P<0.05). The VEGF level was positively correlated with ASM,SM,RASM,grip strength,and gait speed(P<0.05),however,the BMP - 2 level was negatively correlated with these five indexes(P<0.05). Multivariate analysis showed that high BMP-2 was an independent risk factor for senile sarcopenia,while high RASM and VEGF were protective factors for senile sarcopenia(P<0.05). The area under the curve(AUC)of VEGF combined with BMP-2 in diagnosing senile sarcopenia was 0.882,which was better than the AUC of 0.808 for VEGF alone diagnosis and the AUC of 0.793 for BMP-2 alone diagnosis(Z=3.436,Z=3.930,P<0.05). Conclusion Serum VEGF levels decrease and BMP-2 levels increase in senile sarcopenia. The two are closely related to the progression of the disease. Their combined diagnostic efficacy is excellent,and they are expected to become clinical predictive markers for senile sarcopenia.
keywords: Vascular endothelial growth factor Bone morphogenetic protein⁃2 Sarcopenia Elderly Diagnosis
文章编号: 中图分类号:R592 文献标志码:A
基金项目:湖北省卫生健康委员会科研项目(WJ2023F035)
附件
| Author Name | Affiliation |
| DAI Lixing,LUO Wei,CAO Mengying | Department of General Medicine,Third People's Hospital of Hubei Province Affiliated to Jianghan University,Wuhan,Hubei 430033,China |
引用文本:
戴丽星,罗玮,曹梦莹.血清血管内皮生长因子和骨形态发生蛋白⁃2在老年肌肉减少症患者中的诊断价值[J].中国临床研究,2025,38(11):1710-1714.
戴丽星,罗玮,曹梦莹.血清血管内皮生长因子和骨形态发生蛋白⁃2在老年肌肉减少症患者中的诊断价值[J].中国临床研究,2025,38(11):1710-1714.
